Partial deletion of the MAPT gene: A novel mechanism of FTDP-17

Human Mutation

Volumn 30, Issue 4, 2009, Pages

  Rovelet Lecrux, Anne ^a   Lecourtois, Magalie ^a   Thomas Anterion, Catherine ^b   Ber, Isabelle Le ^a   Brice, Alexis ^a   Frebourg, Thierry ^a   Hannequin, Didier ^a   Campion, Dominique ^a  

^a INSERM   (France)

^b UNIVERSITY HOSPITAL OF SAINT ETIENNE   (France)

Author keywords

Deletion; FTDP 17; MAP 1B; MAPT

Indexed keywords

ISOPROTEIN; MICROTUBULE ASSOCIATED PROTEIN 5; TAU PROTEIN;

ARTICLE; CELL CULTURE; CHROMOSOME 17; CONTROLLED STUDY; EXON; FRONTOTEMPORAL DEMENTIA; GENE DELETION; GENE SEQUENCE; GENETIC TRANSCRIPTION; HETEROZYGOTE; HUMAN; HUMAN CELL; LOSS OF FUNCTION MUTATION; MAJOR CLINICAL STUDY; MICROTUBULE; NEUROBLASTOMA CELL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEIN PHOSPHORYLATION; TAUOPATHY;

ADULT; ALTERNATIVE SPLICING; BLOTTING, WESTERN; CELL LINE, TUMOR; DNA MUTATIONAL ANALYSIS; FATAL OUTCOME; GENE DELETION; HUMANS; IMMUNOPRECIPITATION; MALE; MICROSCOPY, CONFOCAL; MICROTUBULE-ASSOCIATED PROTEINS; MICROTUBULES; PROTEIN BINDING; PROTEIN ISOFORMS; TAU PROTEINS; TAUOPATHIES; TRANSFECTION;

EID: 63749104739     PISSN: 10597794     EISSN: None     Source Type: Journal    
DOI: 10.1002/humu.20979     Document Type: Article

References (37)

1. 1994. Clinical and neuropathological criteria for frontotemporal dementia. The Lund and Manchester Groups. J Neurol Neurosurg Psychiatry 57(4):416-8.
2. Abraha A, Ghoshal N, Gamblin TC, Cryns V, Berry RW, Kuret J, Binder LI. 2000. C-terminal inhibition of tau assembly in vitro and in Alzheimer's disease. J Cell Sci 113 Pt 21:3737-45.
3. Alonso AC, Grundke-Iqbal I, Iqbal K. 1996. Alzheimer's disease hyperphosphorylated tau sequesters normal tau into tangles of filaments and disassembles microtubules. Nat Med 2(7):783-7.
4. Alonso AD, Grundke-Iqbal I, Barra HS, Iqbal K. 1997. Abnormal phosphorylation of tau and the mechanism of Alzheimer neurofibrillary degeneration: sequestration of microtubule-associated proteins 1 and 2 and the disassembly of microtubules by the abnormal tau. Proc Natl Acad Sci U S A 94(1):298-303.
5. Barghorn S, Zheng-Fischhofer Q, Ackmann M, Biernat J, von Bergen M, Mandelkow EM, Mandelkow E. 2000. Structure, microtubule interactions, and paired helical filament aggregation by tau mutants of frontotemporal dementias. Biochemistry 39(38):11714-21.
6. Brandt R, Hundelt M, Shahani N. 2005. Tau alteration and neuronal degeneration in tauopathies: mechanisms and models. Biochim Biophys Acta 1739(2-3):331-54.
7. Buee-Scherrer V, Condamines O, Mourton-Gilles C, Jakes R, Goedert M, Pau B, Delacourte A. 1996. AD2, a phosphorylation- dependent monoclonal antibody directed against tau proteins found in Alzheimer's disease. Brain Res Mol Brain Res 39(1-2):79-88.
8. Butner KA, Kirschner MW. 1991. Tau protein binds to microtubules through a flexible array of distributed weak sites. J Cell Biol 115(3):717-30.
9. D'Souza I, Schellenberg GD. 2005. Regulation of tau isoform expression and dementia. Biochim Biophys Acta 1739(2-3):104-15.
10. Dawson HN, Ferreira A, Eyster MV, Ghoshal N, Binder LI, Vitek MP. 2001. Inhibition of neuronal maturation in primary hippocampal neurons from tau deficient mice. J Cell Sci 114(Pt 6):1179-87.
11. Dayanandan R, Van Slegtenhorst M, Mack TG, Ko L, Yen SH, Leroy K, Brion JP, Anderton BH, Hutton M, Lovestone S. 1999. Mutations in tau reduce its microtubule binding properties in intact cells and affect its phosphorylation. FEBS Lett 446(2-3):228-32.
12. DeTure M, Ko LW, Yen S, Nacharaju P, Easson C, Lewis J, van Slegtenhorst M, Hutton M, Yen SH. 2000. Missense tau mutations identified in FTDP-17 have a small effect on tau-microtubule interactions. Brain Res 853(1):5-14.
13. Dumanchin C, Camuzat A, Campion D, Verpillat P, Hannequin D, Dubois B, Saugier-Veber P, Martin C, Penet C, Charbonnier F, Agid Y, Frebourg T, Brice A. 1998. Segregation of a missense mutation in the microtubule-associated protein tau gene with familial frontotemporal dementia and parkinsonism. Hum Mol Genet 7(11):1825-9.
14. Feinstein SC, Wilson L. 2005. Inability of tau to properly regulate neuronal microtubule dynamics: a loss-of-function mechanism by which tau might mediate neuronal cell death. Biochim Biophys Acta 1739(2-3):268-79.
15. Goedert M, Jakes R. 2005. Mutations causing neurodegenerative tauopathies. Biochim Biophys Acta 1739(2-3):240-50.
16. Goode BL, Chau M, Denis PE, Feinstein SC. 2000. Structural and functional differences between 3-repeat and 4-repeat tau isoforms. Implications for normal tau function and the onset of neurodegenetative disease. J Biol Chem 275(49):38182-9.
17. Gustke N, Trinczek B, Biernat J, Mandelkow EM, Mandelkow E. 1994. Domains of tau protein and interactions with microtubules. Biochemistry 33(32):9511-22.
18. Guyant-Marechal L, Laquerriere A, Duyckaerts C, Dumanchin C, Bou J, Dugny F, Le Ber I, Frebourg T, Hannequin D, Campion D. 2006. Valosin-containing protein gene mutations: clinical and neuropathologic features. Neurology 67(4):644-51.
19. Harada A, Oguchi K, Okabe S, Kuno J, Terada S, Ohshima T, Sato-Yoshitake R, Takei Y, Noda T, Hirokawa N. 1994. Altered microtubule organization in small-calibre axons of mice lacking tau protein. Nature 369(6480):488-91.
20. Hong M, Zhukareva V, Vogelsberg-Ragaglia V, Wszolek Z, Reed L, Miller BI, Geschwind DH, Bird TD, McKeel D, Goate A, Morris JC, Wilhelmsen KC, Schellenberg GD, Trojanowski JQ, Lee VM. 1998. Mutation-specific functional impairments in distinct tau isoforms of hereditary FTDP-17. Science 282(5395):1914-7.
21. Iqbal K, Alonso Adel C, Chen S, Chohan MO, El-Akkad E, Gong CX, Khatoon S, Li B, Liu F, Rahman A, Tanimukai H, Grundke-Iqbal I. 2005. Tau pathology in Alzheimer disease and other tauopathies. Biochim Biophys Acta 1739(2-3):198-210.
22. Jicha GA, Bowser R, Kazam IG, Davies P. 1997. Alz-50 and MC-1, a new monoclonal antibody raised to paired helical filaments, recognize conformational epitopes on recombinant tau. J Neurosci Res 48(2):128-32.
23. Kanai Y, Takemura R, Oshima T, Mori H, Ihara Y, Yanagisawa M, Masaki T, Hirokawa N. 1989. Expression of multiple tau isoforms and microtubule bundle formation in fibroblasts transfected with a single tau cDNA. J Cell Biol 109(3):1173-84.
24. Koolen DA, Vissers LE, Pfundt R, de Leeuw N, Knight SJ, Regan R, Kooy RF, Reyniers E, Romano C, Fichera M, Schinzel A, Baumer A, Anderlid BM, Schoumans J, Knoers NV, van Kessel AG, Sistermans EA, Veltman JA, Brunner HG, de Vries BB. 2006. A new chromosome 17q21.31 microdeletion syndrome associated with a common inversion polymorphism. Nat Genet 38(9):999-1001.
25. Le Ber I, van der Zee J, Hannequin D, Gijselinck I, Campion D, Puel M, Laquerriere A, De Pooter T, Camuzat A, Van den Broeck M, Dubois B, Sellal F, Lacomblez L, Vercelletto M, Thomas-Anterion C, Michel BF, Golfier V, Didic M, Salachas F, Duyckaerts C, Cruts M, Verpillat P, Van Broeckhoven C, Brice A; French Research Network on FTD/FTD-MND. 2007. Progranulin null mutations in both sporadic and familial frontotemporal dementia. Hum Mutat 28(9):846-55.
26. Lee G, Rook SL. 1992. Expression of tau protein in non-neuronal cells: microtubule binding and stabilization. J Cell Sci 102 ( Pt 2):227-37.
27. B, Chohan MO, Grundke-Iqbal I, Iqbal K. 2007. Disruption of microtubule network by Alzheimer abnormally hyperphosphorylated tau. Acta Neuropathol 113(5):501-11.
28. Llado A, Rodriguez-Santiago B, Antonell A, Sanchez-Valle R, Molinuevo JL, Rene R, Perez-Jurado LA. 2007. MAPT gene duplications are not a cause of frontotemporal lobar degeneration. Neurosci Lett 424(1):61-5.
29. Luo MH, Tse SW, Memmott J, Andreadis A. 2004. Novel isoforms of tau that lack the microtubule-binding domain. J Neurochem 90(2):340-51.
30. Malkani R, D'Souza I, Gwinn-Hardy K, Schellenberg GD, Hardy J, Momeni P. 2006. A MAPT mutation in a regulatory element upstream of exon 10 causes frontotemporal dementia. Neurobiol Dis 22(2):401-3.
31. Merrick SE, Trojanowski JQ, Lee VM. 1997. Selective destruction of stable microtubules and axons by inhibitors of protein serine/threonine phosphatases in cultured human neurons. J Neurosci 17(15):5726-37.
32. Nagiec EW, Sampson KE, Abraham I. 2001. Mutated tau binds less avidly to microtubules than wildtype tau in living cells. J Neurosci Res 63(3):268-75.
33. Redon R, Ishikawa S, Fitch KR, Feuk L, Perry GH, Andrews TD, Fiegler H, Shapero MH, Carson AR, Chen W et al.,. 2006. Global variation in copy number in the human genome. Nature 444(7118):444-54.
34. Shaw-Smith C, Pittman AM, Willatt L, Martin H, Rickman L, Gribble S, Curley R, Cumming S, Dunn C, Kalaitzopoulos D et al.,. 2006. Microdeletion encompassing MAPT at chromosome 17q21.3 is associated with developmental delay and learning disability. Nat Genet 38(9):1032-7.
35. Takei Y, Teng J, Harada A, Hirokawa N. 2000. Defects in axonal elongation and neuronal migration in mice with disrupted tau and map1b genes. J Cell Biol 150(5):989-1000.
36. Tanaka T, Iqbal K, Trenkner E, Liu DJ, Grundke-Iqbal I. 1995. Abnormally phosphorylated tau in SY5Y human neuroblastoma cells. FEBS Lett 360(1):5-9.
37. Xu G, Gonzales V, Borchelt DR. 2002. Rapid detection of protein aggregates in the brains of Alzheimer patients and transgenic mouse models of amyloidosis. Alzheimer Dis Assoc Disord 16(3):191-5.